nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP2D6—Lomustine—brain cancer	0.105	0.187	CbGbCtD
Pentamidine—CYP1A2—Carmustine—brain cancer	0.104	0.185	CbGbCtD
Pentamidine—CYP2D6—Hydroxyurea—brain cancer	0.0799	0.142	CbGbCtD
Pentamidine—CYP3A4—Temozolomide—brain cancer	0.0789	0.14	CbGbCtD
Pentamidine—CYP3A4—Lomustine—brain cancer	0.067	0.119	CbGbCtD
Pentamidine—CYP3A5—Etoposide—brain cancer	0.0416	0.0737	CbGbCtD
Pentamidine—CYP2C8—Etoposide—brain cancer	0.04	0.0708	CbGbCtD
Pentamidine—CYP1A2—Etoposide—brain cancer	0.0309	0.0548	CbGbCtD
Pentamidine—CYP3A4—Etoposide—brain cancer	0.0162	0.0287	CbGbCtD
Pentamidine—S100B—ganglion—brain cancer	0.00877	0.153	CbGeAlD
Pentamidine—CYP4A11—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00772	0.0621	CbGpPWpGaD
Pentamidine—S100B—blood vessel—brain cancer	0.00697	0.122	CbGeAlD
Pentamidine—S100B—hindbrain—brain cancer	0.00665	0.116	CbGeAlD
Pentamidine—Ospemifene—CYP2C9—brain cancer	0.00542	1	CrCbGaD
Pentamidine—S100B—brainstem—brain cancer	0.00381	0.0664	CbGeAlD
Pentamidine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00343	0.0276	CbGpPWpGaD
Pentamidine—S100B—telencephalon—brain cancer	0.00338	0.059	CbGeAlD
Pentamidine—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00336	0.0271	CbGpPWpGaD
Pentamidine—S100B—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00314	0.0253	CbGpPWpGaD
Pentamidine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00308	0.0248	CbGpPWpGaD
Pentamidine—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00306	0.0247	CbGpPWpGaD
Pentamidine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00281	0.0226	CbGpPWpGaD
Pentamidine—CYP4A11—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0028	0.0225	CbGpPWpGaD
Pentamidine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00275	0.0222	CbGpPWpGaD
Pentamidine—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00266	0.0214	CbGpPWpGaD
Pentamidine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00251	0.0202	CbGpPWpGaD
Pentamidine—AOC1—endocrine gland—brain cancer	0.00245	0.0427	CbGeAlD
Pentamidine—S100B—midbrain—brain cancer	0.00243	0.0423	CbGeAlD
Pentamidine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00239	0.0192	CbGpPWpGaD
Pentamidine—S100B—spinal cord—brain cancer	0.00237	0.0413	CbGeAlD
Pentamidine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00215	0.0173	CbGpPWpGaD
Pentamidine—S100B—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—RELA—brain cancer	0.00214	0.0173	CbGpPWpGaD
Pentamidine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00213	0.0172	CbGpPWpGaD
Pentamidine—S100B—endocrine gland—brain cancer	0.00213	0.0372	CbGeAlD
Pentamidine—S100B—head—brain cancer	0.00211	0.0367	CbGeAlD
Pentamidine—CYP4A11—endocrine gland—brain cancer	0.00203	0.0354	CbGeAlD
Pentamidine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00196	0.0158	CbGpPWpGaD
Pentamidine—CYP4A11—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00196	0.0158	CbGpPWpGaD
Pentamidine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00195	0.0157	CbGpPWpGaD
Pentamidine—S100B—central nervous system—brain cancer	0.00192	0.0335	CbGeAlD
Pentamidine—S100B—cerebellum—brain cancer	0.00188	0.0328	CbGeAlD
Pentamidine—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00171	0.0138	CbGpPWpGaD
Pentamidine—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00169	0.0136	CbGpPWpGaD
Pentamidine—CYP4A11—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00167	0.0134	CbGpPWpGaD
Pentamidine—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00165	0.0132	CbGpPWpGaD
Pentamidine—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00162	0.013	CbGpPWpGaD
Pentamidine—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00155	0.0125	CbGpPWpGaD
Pentamidine—S100B—brain—brain cancer	0.00153	0.0266	CbGeAlD
Pentamidine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00148	0.0119	CbGpPWpGaD
Pentamidine—S100B—RIP-mediated NFkB activation via ZBP1—RELA—brain cancer	0.00146	0.0118	CbGpPWpGaD
Pentamidine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00143	0.0115	CbGpPWpGaD
Pentamidine—CYP4A11—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00137	0.011	CbGpPWpGaD
Pentamidine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00132	0.0106	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated NF-kB activation—RELA—brain cancer	0.00131	0.0106	CbGpPWpGaD
Pentamidine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00127	0.0102	CbGpPWpGaD
Pentamidine—S100B—ZBP1(DAI) mediated induction of type I IFNs—RELA—brain cancer	0.00123	0.00991	CbGpPWpGaD
Pentamidine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—brain cancer	0.00123	0.00991	CbGpPWpGaD
Pentamidine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00122	0.00979	CbGpPWpGaD
Pentamidine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00117	0.00946	CbGpPWpGaD
Pentamidine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00117	0.00942	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—GFAP—brain cancer	0.00106	0.00852	CbGpPWpGaD
Pentamidine—CYP2D6—hindbrain—brain cancer	0.00104	0.0181	CbGeAlD
Pentamidine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00103	0.0083	CbGpPWpGaD
Pentamidine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000991	0.00798	CbGpPWpGaD
Pentamidine—CYP4A11—PPAR Alpha Pathway—CDK4—brain cancer	0.00093	0.00749	CbGpPWpGaD
Pentamidine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000908	0.00731	CbGpPWpGaD
Pentamidine—Chills—Procarbazine—brain cancer	0.000796	0.0032	CcSEcCtD
Pentamidine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000795	0.0064	CbGpPWpGaD
Pentamidine—Arrhythmia—Procarbazine—brain cancer	0.000792	0.00318	CcSEcCtD
Pentamidine—Body temperature increased—Lomustine—brain cancer	0.000784	0.00315	CcSEcCtD
Pentamidine—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000777	0.00625	CbGpPWpGaD
Pentamidine—Face oedema—Carmustine—brain cancer	0.000774	0.00311	CcSEcCtD
Pentamidine—Mouth ulceration—Etoposide—brain cancer	0.000772	0.0031	CcSEcCtD
Pentamidine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000765	0.00616	CbGpPWpGaD
Pentamidine—Drowsiness—Hydroxyurea—brain cancer	0.000764	0.00307	CcSEcCtD
Pentamidine—Affect lability—Temozolomide—brain cancer	0.000763	0.00307	CcSEcCtD
Pentamidine—Tension—Procarbazine—brain cancer	0.000757	0.00304	CcSEcCtD
Pentamidine—Nervousness—Procarbazine—brain cancer	0.00075	0.00301	CcSEcCtD
Pentamidine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000749	0.00301	CcSEcCtD
Pentamidine—Face oedema—Temozolomide—brain cancer	0.000748	0.00301	CcSEcCtD
Pentamidine—Stomatitis—Hydroxyurea—brain cancer	0.000745	0.00299	CcSEcCtD
Pentamidine—Sepsis—Etoposide—brain cancer	0.000741	0.00298	CcSEcCtD
Pentamidine—Liver function test abnormal—Carmustine—brain cancer	0.00074	0.00298	CcSEcCtD
Pentamidine—Mood swings—Temozolomide—brain cancer	0.000734	0.00295	CcSEcCtD
Pentamidine—CYP4A11—Biological oxidations—CYP2C9—brain cancer	0.000728	0.00586	CbGpPWpGaD
Pentamidine—Tremor—Procarbazine—brain cancer	0.000723	0.00291	CcSEcCtD
Pentamidine—Phlebitis—Etoposide—brain cancer	0.00072	0.00289	CcSEcCtD
Pentamidine—Anaemia—Procarbazine—brain cancer	0.000713	0.00287	CcSEcCtD
Pentamidine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000712	0.00573	CbGpPWpGaD
Pentamidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00071	0.00572	CbGpPWpGaD
Pentamidine—Dry skin—Temozolomide—brain cancer	0.00071	0.00285	CcSEcCtD
Pentamidine—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000701	0.00564	CbGpPWpGaD
Pentamidine—Syncope—Procarbazine—brain cancer	0.000692	0.00278	CcSEcCtD
Pentamidine—Leukopenia—Procarbazine—brain cancer	0.000691	0.00278	CcSEcCtD
Pentamidine—Hallucination—Hydroxyurea—brain cancer	0.000683	0.00274	CcSEcCtD
Pentamidine—Loss of consciousness—Procarbazine—brain cancer	0.000678	0.00273	CcSEcCtD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000674	0.00543	CbGpPWpGaD
Pentamidine—Cough—Procarbazine—brain cancer	0.000674	0.00271	CcSEcCtD
Pentamidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000671	0.0054	CbGpPWpGaD
Pentamidine—Convulsion—Procarbazine—brain cancer	0.000669	0.00269	CcSEcCtD
Pentamidine—Hypertension—Procarbazine—brain cancer	0.000666	0.00268	CcSEcCtD
Pentamidine—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000662	0.00533	CbGpPWpGaD
Pentamidine—Pancytopenia—Carmustine—brain cancer	0.000658	0.00264	CcSEcCtD
Pentamidine—Myalgia—Procarbazine—brain cancer	0.000657	0.00264	CcSEcCtD
Pentamidine—Arthralgia—Procarbazine—brain cancer	0.000657	0.00264	CcSEcCtD
Pentamidine—Anxiety—Procarbazine—brain cancer	0.000655	0.00263	CcSEcCtD
Pentamidine—Neutropenia—Carmustine—brain cancer	0.000648	0.0026	CcSEcCtD
Pentamidine—CYP2C8—pituitary gland—brain cancer	0.000645	0.0112	CbGeAlD
Pentamidine—Bronchitis—Temozolomide—brain cancer	0.000644	0.00259	CcSEcCtD
Pentamidine—Dry mouth—Procarbazine—brain cancer	0.000643	0.00258	CcSEcCtD
Pentamidine—Pancytopenia—Temozolomide—brain cancer	0.000636	0.00256	CcSEcCtD
Pentamidine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000636	0.00512	CbGpPWpGaD
Pentamidine—Confusional state—Procarbazine—brain cancer	0.000635	0.00255	CcSEcCtD
Pentamidine—Vomiting—Lomustine—brain cancer	0.000631	0.00254	CcSEcCtD
Pentamidine—Neutropenia—Temozolomide—brain cancer	0.000626	0.00252	CcSEcCtD
Pentamidine—Infection—Procarbazine—brain cancer	0.000626	0.00251	CcSEcCtD
Pentamidine—Hyperglycaemia—Carmustine—brain cancer	0.000625	0.00251	CcSEcCtD
Pentamidine—Shock—Procarbazine—brain cancer	0.00062	0.00249	CcSEcCtD
Pentamidine—Thrombocytopenia—Procarbazine—brain cancer	0.000617	0.00248	CcSEcCtD
Pentamidine—Chills—Hydroxyurea—brain cancer	0.000616	0.00247	CcSEcCtD
Pentamidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000615	0.00495	CbGpPWpGaD
Pentamidine—Tachycardia—Procarbazine—brain cancer	0.000615	0.00247	CcSEcCtD
Pentamidine—Renal failure—Carmustine—brain cancer	0.000607	0.00244	CcSEcCtD
Pentamidine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000607	0.00489	CbGpPWpGaD
Pentamidine—Neuropathy peripheral—Carmustine—brain cancer	0.000606	0.00243	CcSEcCtD
Pentamidine—S100B—Signaling by ERBB4—VAV1—brain cancer	0.000604	0.00487	CbGpPWpGaD
Pentamidine—Hyperglycaemia—Temozolomide—brain cancer	0.000604	0.00243	CcSEcCtD
Pentamidine—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000603	0.00486	CbGpPWpGaD
Pentamidine—Stomatitis—Carmustine—brain cancer	0.000602	0.00242	CcSEcCtD
Pentamidine—CYP4A11—PPAR Alpha Pathway—CCND1—brain cancer	0.000601	0.00484	CbGpPWpGaD
Pentamidine—Anorexia—Procarbazine—brain cancer	0.0006	0.00241	CcSEcCtD
Pentamidine—Erythema—Hydroxyurea—brain cancer	0.000597	0.0024	CcSEcCtD
Pentamidine—CYP2D6—brainstem—brain cancer	0.000595	0.0104	CbGeAlD
Pentamidine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000592	0.00238	CcSEcCtD
Pentamidine—Nausea—Lomustine—brain cancer	0.000589	0.00237	CcSEcCtD
Pentamidine—Hypotension—Procarbazine—brain cancer	0.000589	0.00237	CcSEcCtD
Pentamidine—Neuropathy peripheral—Temozolomide—brain cancer	0.000585	0.00235	CcSEcCtD
Pentamidine—S100B—Cytosolic sensors of pathogen-associated DNA—RELA—brain cancer	0.000585	0.00471	CbGpPWpGaD
Pentamidine—Stomatitis—Temozolomide—brain cancer	0.000582	0.00234	CcSEcCtD
Pentamidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000576	0.00464	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000574	0.00231	CcSEcCtD
Pentamidine—CYP2C19—endocrine gland—brain cancer	0.000572	0.00997	CbGeAlD
Pentamidine—Insomnia—Procarbazine—brain cancer	0.00057	0.00229	CcSEcCtD
Pentamidine—Paraesthesia—Procarbazine—brain cancer	0.000566	0.00227	CcSEcCtD
Pentamidine—Sinusitis—Temozolomide—brain cancer	0.00056	0.00225	CcSEcCtD
Pentamidine—Somnolence—Procarbazine—brain cancer	0.00056	0.00225	CcSEcCtD
Pentamidine—Anaemia—Hydroxyurea—brain cancer	0.000552	0.00222	CcSEcCtD
Pentamidine—Hypoaesthesia—Carmustine—brain cancer	0.000552	0.00222	CcSEcCtD
Pentamidine—Hallucination—Carmustine—brain cancer	0.000552	0.00222	CcSEcCtD
Pentamidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000549	0.00442	CbGpPWpGaD
Pentamidine—Decreased appetite—Procarbazine—brain cancer	0.000548	0.0022	CcSEcCtD
Pentamidine—Oedema peripheral—Carmustine—brain cancer	0.000546	0.0022	CcSEcCtD
Pentamidine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000546	0.0044	CbGpPWpGaD
Pentamidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000544	0.00438	CbGpPWpGaD
Pentamidine—Fatigue—Procarbazine—brain cancer	0.000543	0.00218	CcSEcCtD
Pentamidine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000542	0.00436	CbGpPWpGaD
Pentamidine—Constipation—Procarbazine—brain cancer	0.000539	0.00216	CcSEcCtD
Pentamidine—Pain—Procarbazine—brain cancer	0.000539	0.00216	CcSEcCtD
Pentamidine—Hepatitis—Temozolomide—brain cancer	0.000536	0.00215	CcSEcCtD
Pentamidine—Leukopenia—Hydroxyurea—brain cancer	0.000535	0.00215	CcSEcCtD
Pentamidine—Hallucination—Temozolomide—brain cancer	0.000533	0.00214	CcSEcCtD
Pentamidine—Hypoaesthesia—Temozolomide—brain cancer	0.000533	0.00214	CcSEcCtD
Pentamidine—Pharyngitis—Temozolomide—brain cancer	0.000532	0.00214	CcSEcCtD
Pentamidine—Oedema peripheral—Temozolomide—brain cancer	0.000528	0.00212	CcSEcCtD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—brain cancer	0.000528	0.00425	CbGpPWpGaD
Pentamidine—CYP2D6—telencephalon—brain cancer	0.000528	0.0092	CbGeAlD
Pentamidine—Bronchospasm—Etoposide—brain cancer	0.000527	0.00212	CcSEcCtD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00052	0.00419	CbGpPWpGaD
Pentamidine—Feeling abnormal—Procarbazine—brain cancer	0.000519	0.00209	CcSEcCtD
Pentamidine—Convulsion—Hydroxyurea—brain cancer	0.000518	0.00208	CcSEcCtD
Pentamidine—Gastrointestinal pain—Procarbazine—brain cancer	0.000515	0.00207	CcSEcCtD
Pentamidine—Flushing—Carmustine—brain cancer	0.000515	0.00207	CcSEcCtD
Pentamidine—Pancytopenia—Etoposide—brain cancer	0.000509	0.00205	CcSEcCtD
Pentamidine—S100B—Cytosolic sensors of pathogen-associated DNA—CTNNB1—brain cancer	0.000508	0.00409	CbGpPWpGaD
Pentamidine—Erythema multiforme—Temozolomide—brain cancer	0.000507	0.00204	CcSEcCtD
Pentamidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000505	0.00407	CbGpPWpGaD
Pentamidine—Discomfort—Hydroxyurea—brain cancer	0.000502	0.00202	CcSEcCtD
Pentamidine—Neutropenia—Etoposide—brain cancer	0.000501	0.00201	CcSEcCtD
Pentamidine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—brain cancer	0.000501	0.00403	CbGpPWpGaD
Pentamidine—Urticaria—Procarbazine—brain cancer	0.0005	0.00201	CcSEcCtD
Pentamidine—CYP2C8—endocrine gland—brain cancer	0.000499	0.00871	CbGeAlD
Pentamidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000499	0.00402	CbGpPWpGaD
Pentamidine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000499	0.00401	CbGpPWpGaD
Pentamidine—Body temperature increased—Procarbazine—brain cancer	0.000498	0.002	CcSEcCtD
Pentamidine—Abdominal pain—Procarbazine—brain cancer	0.000498	0.002	CcSEcCtD
Pentamidine—Flushing—Temozolomide—brain cancer	0.000498	0.002	CcSEcCtD
Pentamidine—Arrhythmia—Carmustine—brain cancer	0.000496	0.00199	CcSEcCtD
Pentamidine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000495	0.00399	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—PDGFRA—brain cancer	0.000495	0.00398	CbGpPWpGaD
Pentamidine—Infection—Hydroxyurea—brain cancer	0.000484	0.00195	CcSEcCtD
Pentamidine—Erythema—Carmustine—brain cancer	0.000483	0.00194	CcSEcCtD
Pentamidine—CYP4A11—PPAR Alpha Pathway—MYC—brain cancer	0.000482	0.00388	CbGpPWpGaD
Pentamidine—Chills—Temozolomide—brain cancer	0.000481	0.00193	CcSEcCtD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—RELA—brain cancer	0.000477	0.00384	CbGpPWpGaD
Pentamidine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000477	0.00192	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000474	0.0019	CcSEcCtD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.000473	0.00381	CbGpPWpGaD
Pentamidine—Renal failure—Etoposide—brain cancer	0.00047	0.00189	CcSEcCtD
Pentamidine—Neuropathy peripheral—Etoposide—brain cancer	0.000468	0.00188	CcSEcCtD
Pentamidine—CYP1A2—endocrine gland—brain cancer	0.000467	0.00815	CbGeAlD
Pentamidine—Erythema—Temozolomide—brain cancer	0.000467	0.00188	CcSEcCtD
Pentamidine—Stomatitis—Etoposide—brain cancer	0.000466	0.00187	CcSEcCtD
Pentamidine—Anorexia—Hydroxyurea—brain cancer	0.000465	0.00187	CcSEcCtD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.000464	0.00374	CbGpPWpGaD
Pentamidine—Hypersensitivity—Procarbazine—brain cancer	0.000464	0.00187	CcSEcCtD
Pentamidine—CYP1A1—endocrine gland—brain cancer	0.000461	0.00804	CbGeAlD
Pentamidine—Dysgeusia—Temozolomide—brain cancer	0.000457	0.00184	CcSEcCtD
Pentamidine—Vision blurred—Carmustine—brain cancer	0.000455	0.00183	CcSEcCtD
Pentamidine—CYP1A1—head—brain cancer	0.000455	0.00793	CbGeAlD
Pentamidine—Tremor—Carmustine—brain cancer	0.000452	0.00182	CcSEcCtD
Pentamidine—Asthenia—Procarbazine—brain cancer	0.000452	0.00182	CcSEcCtD
Pentamidine—CYP3A5—endocrine gland—brain cancer	0.000451	0.00786	CbGeAlD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.000448	0.00361	CbGpPWpGaD
Pentamidine—Anaemia—Carmustine—brain cancer	0.000446	0.00179	CcSEcCtD
Pentamidine—Pruritus—Procarbazine—brain cancer	0.000446	0.00179	CcSEcCtD
Pentamidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000445	0.00358	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—RELA—brain cancer	0.00044	0.00355	CbGpPWpGaD
Pentamidine—Vision blurred—Temozolomide—brain cancer	0.00044	0.00177	CcSEcCtD
Pentamidine—Tremor—Temozolomide—brain cancer	0.000437	0.00176	CcSEcCtD
Pentamidine—Dyspnoea—Hydroxyurea—brain cancer	0.000435	0.00175	CcSEcCtD
Pentamidine—S100B—Signaling by ERBB4—IRS2—brain cancer	0.000435	0.0035	CbGpPWpGaD
Pentamidine—Somnolence—Hydroxyurea—brain cancer	0.000433	0.00174	CcSEcCtD
Pentamidine—Leukopenia—Carmustine—brain cancer	0.000432	0.00174	CcSEcCtD
Pentamidine—Anaemia—Temozolomide—brain cancer	0.000431	0.00173	CcSEcCtD
Pentamidine—Diarrhoea—Procarbazine—brain cancer	0.000431	0.00173	CcSEcCtD
Pentamidine—Dyspepsia—Hydroxyurea—brain cancer	0.000429	0.00172	CcSEcCtD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000428	0.00345	CbGpPWpGaD
Pentamidine—Hypoaesthesia—Etoposide—brain cancer	0.000427	0.00172	CcSEcCtD
Pentamidine—Angioedema—Temozolomide—brain cancer	0.000426	0.00171	CcSEcCtD
Pentamidine—Decreased appetite—Hydroxyurea—brain cancer	0.000424	0.0017	CcSEcCtD
Pentamidine—S100B—MyD88-independent cascade—RELA—brain cancer	0.000423	0.0034	CbGpPWpGaD
Pentamidine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000422	0.0034	CbGpPWpGaD
Pentamidine—Fatigue—Hydroxyurea—brain cancer	0.00042	0.00169	CcSEcCtD
Pentamidine—Vertigo—Temozolomide—brain cancer	0.000419	0.00168	CcSEcCtD
Pentamidine—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000419	0.00337	CbGpPWpGaD
Pentamidine—Convulsion—Carmustine—brain cancer	0.000418	0.00168	CcSEcCtD
Pentamidine—Leukopenia—Temozolomide—brain cancer	0.000418	0.00168	CcSEcCtD
Pentamidine—Hypertension—Carmustine—brain cancer	0.000417	0.00168	CcSEcCtD
Pentamidine—Pain—Hydroxyurea—brain cancer	0.000417	0.00168	CcSEcCtD
Pentamidine—Constipation—Hydroxyurea—brain cancer	0.000417	0.00168	CcSEcCtD
Pentamidine—Dizziness—Procarbazine—brain cancer	0.000417	0.00167	CcSEcCtD
Pentamidine—CYP1A1—central nervous system—brain cancer	0.000415	0.00724	CbGeAlD
Pentamidine—Palpitations—Temozolomide—brain cancer	0.000412	0.00166	CcSEcCtD
Pentamidine—Myalgia—Carmustine—brain cancer	0.000411	0.00165	CcSEcCtD
Pentamidine—Chest pain—Carmustine—brain cancer	0.000411	0.00165	CcSEcCtD
Pentamidine—Anxiety—Carmustine—brain cancer	0.00041	0.00165	CcSEcCtD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00041	0.0033	CbGpPWpGaD
Pentamidine—Cough—Temozolomide—brain cancer	0.000407	0.00164	CcSEcCtD
Pentamidine—Erythema multiforme—Etoposide—brain cancer	0.000406	0.00163	CcSEcCtD
Pentamidine—Convulsion—Temozolomide—brain cancer	0.000404	0.00162	CcSEcCtD
Pentamidine—Hypertension—Temozolomide—brain cancer	0.000403	0.00162	CcSEcCtD
Pentamidine—Feeling abnormal—Hydroxyurea—brain cancer	0.000402	0.00161	CcSEcCtD
Pentamidine—Vomiting—Procarbazine—brain cancer	0.000401	0.00161	CcSEcCtD
Pentamidine—Flushing—Etoposide—brain cancer	0.000398	0.0016	CcSEcCtD
Pentamidine—Confusional state—Carmustine—brain cancer	0.000397	0.0016	CcSEcCtD
Pentamidine—Myalgia—Temozolomide—brain cancer	0.000397	0.0016	CcSEcCtD
Pentamidine—Arthralgia—Temozolomide—brain cancer	0.000397	0.0016	CcSEcCtD
Pentamidine—Rash—Procarbazine—brain cancer	0.000397	0.0016	CcSEcCtD
Pentamidine—Dermatitis—Procarbazine—brain cancer	0.000397	0.00159	CcSEcCtD
Pentamidine—Anxiety—Temozolomide—brain cancer	0.000396	0.00159	CcSEcCtD
Pentamidine—Headache—Procarbazine—brain cancer	0.000395	0.00159	CcSEcCtD
Pentamidine—Discomfort—Temozolomide—brain cancer	0.000393	0.00158	CcSEcCtD
Pentamidine—Infection—Carmustine—brain cancer	0.000392	0.00157	CcSEcCtD
Pentamidine—Dry mouth—Temozolomide—brain cancer	0.000389	0.00156	CcSEcCtD
Pentamidine—Thrombocytopenia—Carmustine—brain cancer	0.000386	0.00155	CcSEcCtD
Pentamidine—Body temperature increased—Hydroxyurea—brain cancer	0.000385	0.00155	CcSEcCtD
Pentamidine—Chills—Etoposide—brain cancer	0.000385	0.00155	CcSEcCtD
Pentamidine—Tachycardia—Carmustine—brain cancer	0.000385	0.00155	CcSEcCtD
Pentamidine—Confusional state—Temozolomide—brain cancer	0.000384	0.00154	CcSEcCtD
Pentamidine—Anaphylactic shock—Temozolomide—brain cancer	0.000381	0.00153	CcSEcCtD
Pentamidine—S100B—Activated TLR4 signalling—RELA—brain cancer	0.00038	0.00306	CbGpPWpGaD
Pentamidine—Infection—Temozolomide—brain cancer	0.000378	0.00152	CcSEcCtD
Pentamidine—Anorexia—Carmustine—brain cancer	0.000376	0.00151	CcSEcCtD
Pentamidine—Nausea—Procarbazine—brain cancer	0.000374	0.0015	CcSEcCtD
Pentamidine—Thrombocytopenia—Temozolomide—brain cancer	0.000373	0.0015	CcSEcCtD
Pentamidine—Hypotension—Carmustine—brain cancer	0.000368	0.00148	CcSEcCtD
Pentamidine—Dysgeusia—Etoposide—brain cancer	0.000366	0.00147	CcSEcCtD
Pentamidine—Anorexia—Temozolomide—brain cancer	0.000363	0.00146	CcSEcCtD
Pentamidine—Hypersensitivity—Hydroxyurea—brain cancer	0.000359	0.00144	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000359	0.00144	CcSEcCtD
Pentamidine—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000358	0.00288	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.000358	0.00288	CbGpPWpGaD
Pentamidine—CYP2C8—brain—brain cancer	0.000357	0.00623	CbGeAlD
Pentamidine—Insomnia—Carmustine—brain cancer	0.000356	0.00143	CcSEcCtD
Pentamidine—Paraesthesia—Carmustine—brain cancer	0.000354	0.00142	CcSEcCtD
Pentamidine—Dyspnoea—Carmustine—brain cancer	0.000351	0.00141	CcSEcCtD
Pentamidine—Somnolence—Carmustine—brain cancer	0.00035	0.00141	CcSEcCtD
Pentamidine—Asthenia—Hydroxyurea—brain cancer	0.00035	0.00141	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000347	0.00139	CcSEcCtD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000347	0.00279	CbGpPWpGaD
Pentamidine—Anaemia—Etoposide—brain cancer	0.000345	0.00139	CcSEcCtD
Pentamidine—Insomnia—Temozolomide—brain cancer	0.000344	0.00138	CcSEcCtD
Pentamidine—Decreased appetite—Carmustine—brain cancer	0.000343	0.00138	CcSEcCtD
Pentamidine—Paraesthesia—Temozolomide—brain cancer	0.000342	0.00137	CcSEcCtD
Pentamidine—Dyspnoea—Temozolomide—brain cancer	0.00034	0.00136	CcSEcCtD
Pentamidine—Somnolence—Temozolomide—brain cancer	0.000339	0.00136	CcSEcCtD
Pentamidine—CYP3A4—endocrine gland—brain cancer	0.000338	0.0059	CbGeAlD
Pentamidine—Constipation—Carmustine—brain cancer	0.000337	0.00135	CcSEcCtD
Pentamidine—Pain—Carmustine—brain cancer	0.000337	0.00135	CcSEcCtD
Pentamidine—Vertigo—Etoposide—brain cancer	0.000336	0.00135	CcSEcCtD
Pentamidine—Dyspepsia—Temozolomide—brain cancer	0.000335	0.00135	CcSEcCtD
Pentamidine—Leukopenia—Etoposide—brain cancer	0.000334	0.00134	CcSEcCtD
Pentamidine—Diarrhoea—Hydroxyurea—brain cancer	0.000334	0.00134	CcSEcCtD
Pentamidine—CYP2D6—endocrine gland—brain cancer	0.000333	0.0058	CbGeAlD
Pentamidine—Decreased appetite—Temozolomide—brain cancer	0.000331	0.00133	CcSEcCtD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00033	0.00266	CbGpPWpGaD
Pentamidine—CYP1A1—brain—brain cancer	0.00033	0.00575	CbGeAlD
Pentamidine—CYP2D6—head—brain cancer	0.000329	0.00573	CbGeAlD
Pentamidine—Fatigue—Temozolomide—brain cancer	0.000328	0.00132	CcSEcCtD
Pentamidine—Loss of consciousness—Etoposide—brain cancer	0.000328	0.00132	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—OR4C12—brain cancer	0.000326	0.00263	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—OR14C36—brain cancer	0.000326	0.00263	CbGpPWpGaD
Pentamidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000326	0.00262	CbGpPWpGaD
Pentamidine—Cough—Etoposide—brain cancer	0.000326	0.00131	CcSEcCtD
Pentamidine—Pain—Temozolomide—brain cancer	0.000326	0.00131	CcSEcCtD
Pentamidine—Constipation—Temozolomide—brain cancer	0.000326	0.00131	CcSEcCtD
Pentamidine—Feeling abnormal—Carmustine—brain cancer	0.000325	0.00131	CcSEcCtD
Pentamidine—Convulsion—Etoposide—brain cancer	0.000324	0.0013	CcSEcCtD
Pentamidine—Hypertension—Etoposide—brain cancer	0.000322	0.0013	CcSEcCtD
Pentamidine—Dizziness—Hydroxyurea—brain cancer	0.000322	0.0013	CcSEcCtD
Pentamidine—Gastrointestinal pain—Carmustine—brain cancer	0.000322	0.0013	CcSEcCtD
Pentamidine—S100B—Toll-Like Receptors Cascades—RELA—brain cancer	0.000318	0.00256	CbGpPWpGaD
Pentamidine—Chest pain—Etoposide—brain cancer	0.000318	0.00128	CcSEcCtD
Pentamidine—Discomfort—Etoposide—brain cancer	0.000314	0.00126	CcSEcCtD
Pentamidine—Feeling abnormal—Temozolomide—brain cancer	0.000314	0.00126	CcSEcCtD
Pentamidine—Abdominal pain—Carmustine—brain cancer	0.000312	0.00125	CcSEcCtD
Pentamidine—Body temperature increased—Carmustine—brain cancer	0.000312	0.00125	CcSEcCtD
Pentamidine—Gastrointestinal pain—Temozolomide—brain cancer	0.000311	0.00125	CcSEcCtD
Pentamidine—Vomiting—Hydroxyurea—brain cancer	0.00031	0.00125	CcSEcCtD
Pentamidine—Rash—Hydroxyurea—brain cancer	0.000307	0.00124	CcSEcCtD
Pentamidine—Confusional state—Etoposide—brain cancer	0.000307	0.00123	CcSEcCtD
Pentamidine—Dermatitis—Hydroxyurea—brain cancer	0.000307	0.00123	CcSEcCtD
Pentamidine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000306	0.00246	CbGpPWpGaD
Pentamidine—Headache—Hydroxyurea—brain cancer	0.000305	0.00123	CcSEcCtD
Pentamidine—Anaphylactic shock—Etoposide—brain cancer	0.000305	0.00122	CcSEcCtD
Pentamidine—CYP3A4—central nervous system—brain cancer	0.000305	0.00531	CbGeAlD
Pentamidine—Infection—Etoposide—brain cancer	0.000303	0.00122	CcSEcCtD
Pentamidine—Urticaria—Temozolomide—brain cancer	0.000303	0.00122	CcSEcCtD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000302	0.00243	CbGpPWpGaD
Pentamidine—Body temperature increased—Temozolomide—brain cancer	0.000301	0.00121	CcSEcCtD
Pentamidine—Abdominal pain—Temozolomide—brain cancer	0.000301	0.00121	CcSEcCtD
Pentamidine—CYP2D6—central nervous system—brain cancer	0.0003	0.00523	CbGeAlD
Pentamidine—Thrombocytopenia—Etoposide—brain cancer	0.000298	0.0012	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000298	0.0024	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—ERBB2—brain cancer	0.000298	0.0024	CbGpPWpGaD
Pentamidine—Tachycardia—Etoposide—brain cancer	0.000297	0.0012	CcSEcCtD
Pentamidine—CYP2D6—cerebellum—brain cancer	0.000293	0.00511	CbGeAlD
Pentamidine—Anorexia—Etoposide—brain cancer	0.000291	0.00117	CcSEcCtD
Pentamidine—Hypersensitivity—Carmustine—brain cancer	0.00029	0.00117	CcSEcCtD
Pentamidine—Nausea—Hydroxyurea—brain cancer	0.00029	0.00116	CcSEcCtD
Pentamidine—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000289	0.00233	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000285	0.0023	CbGpPWpGaD
Pentamidine—Hypotension—Etoposide—brain cancer	0.000285	0.00114	CcSEcCtD
Pentamidine—Asthenia—Carmustine—brain cancer	0.000283	0.00114	CcSEcCtD
Pentamidine—Hypersensitivity—Temozolomide—brain cancer	0.000281	0.00113	CcSEcCtD
Pentamidine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000281	0.00226	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00028	0.00225	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—DTX2—brain cancer	0.000278	0.00223	CbGpPWpGaD
Pentamidine—Paraesthesia—Etoposide—brain cancer	0.000274	0.0011	CcSEcCtD
Pentamidine—Asthenia—Temozolomide—brain cancer	0.000273	0.0011	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—brain cancer	0.000272	0.00109	CcSEcCtD
Pentamidine—Somnolence—Etoposide—brain cancer	0.000271	0.00109	CcSEcCtD
Pentamidine—Diarrhoea—Carmustine—brain cancer	0.00027	0.00108	CcSEcCtD
Pentamidine—Pruritus—Temozolomide—brain cancer	0.000269	0.00108	CcSEcCtD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000268	0.00216	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000265	0.00213	CbGpPWpGaD
Pentamidine—Decreased appetite—Etoposide—brain cancer	0.000265	0.00106	CcSEcCtD
Pentamidine—Fatigue—Etoposide—brain cancer	0.000263	0.00106	CcSEcCtD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000261	0.0021	CbGpPWpGaD
Pentamidine—Dizziness—Carmustine—brain cancer	0.000261	0.00105	CcSEcCtD
Pentamidine—Pain—Etoposide—brain cancer	0.000261	0.00105	CcSEcCtD
Pentamidine—Constipation—Etoposide—brain cancer	0.000261	0.00105	CcSEcCtD
Pentamidine—Diarrhoea—Temozolomide—brain cancer	0.000261	0.00105	CcSEcCtD
Pentamidine—Dizziness—Temozolomide—brain cancer	0.000252	0.00101	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—brain cancer	0.000251	0.00101	CcSEcCtD
Pentamidine—Vomiting—Carmustine—brain cancer	0.000251	0.00101	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—brain cancer	0.000249	0.001	CcSEcCtD
Pentamidine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000249	0.002	CbGpPWpGaD
Pentamidine—Rash—Carmustine—brain cancer	0.000248	0.000999	CcSEcCtD
Pentamidine—Dermatitis—Carmustine—brain cancer	0.000248	0.000998	CcSEcCtD
Pentamidine—Headache—Carmustine—brain cancer	0.000247	0.000992	CcSEcCtD
Pentamidine—Vomiting—Temozolomide—brain cancer	0.000242	0.000973	CcSEcCtD
Pentamidine—Urticaria—Etoposide—brain cancer	0.000242	0.000973	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—brain cancer	0.000241	0.000968	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—brain cancer	0.000241	0.000968	CcSEcCtD
Pentamidine—Rash—Temozolomide—brain cancer	0.00024	0.000965	CcSEcCtD
Pentamidine—Dermatitis—Temozolomide—brain cancer	0.00024	0.000964	CcSEcCtD
Pentamidine—Headache—Temozolomide—brain cancer	0.000239	0.000959	CcSEcCtD
Pentamidine—CYP2D6—brain—brain cancer	0.000238	0.00415	CbGeAlD
Pentamidine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000237	0.0019	CbGpPWpGaD
Pentamidine—Nausea—Carmustine—brain cancer	0.000234	0.000941	CcSEcCtD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000233	0.00188	CbGpPWpGaD
Pentamidine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000228	0.00184	CbGpPWpGaD
Pentamidine—Nausea—Temozolomide—brain cancer	0.000226	0.000909	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—brain cancer	0.000225	0.000902	CcSEcCtD
Pentamidine—Asthenia—Etoposide—brain cancer	0.000219	0.000879	CcSEcCtD
Pentamidine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000218	0.00175	CbGpPWpGaD
Pentamidine—Pruritus—Etoposide—brain cancer	0.000216	0.000867	CcSEcCtD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000215	0.00173	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTCH2—brain cancer	0.00021	0.00169	CbGpPWpGaD
Pentamidine—Diarrhoea—Etoposide—brain cancer	0.000209	0.000838	CcSEcCtD
Pentamidine—S100B—Innate Immune System—VAV1—brain cancer	0.000208	0.00167	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—EGFR—brain cancer	0.000207	0.00166	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000205	0.00165	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HES5—brain cancer	0.000204	0.00164	CbGpPWpGaD
Pentamidine—Dizziness—Etoposide—brain cancer	0.000202	0.00081	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—STRADA—brain cancer	0.000198	0.00159	CbGpPWpGaD
Pentamidine—Vomiting—Etoposide—brain cancer	0.000194	0.000779	CcSEcCtD
Pentamidine—Rash—Etoposide—brain cancer	0.000192	0.000772	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—brain cancer	0.000192	0.000772	CcSEcCtD
Pentamidine—Headache—Etoposide—brain cancer	0.000191	0.000767	CcSEcCtD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00019	0.00153	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000184	0.00148	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000182	0.00146	CbGpPWpGaD
Pentamidine—Nausea—Etoposide—brain cancer	0.000181	0.000727	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000172	0.00138	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PDGFRA—brain cancer	0.00017	0.00137	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ABR—brain cancer	0.000165	0.00133	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GLI2—brain cancer	0.000159	0.00128	CbGpPWpGaD
Pentamidine—S100B—Immune System—SKP2—brain cancer	0.000159	0.00128	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000155	0.00125	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GLI1—brain cancer	0.00015	0.00121	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—IRS2—brain cancer	0.000149	0.0012	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000142	0.00115	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SUFU—brain cancer	0.000142	0.00114	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00014	0.00113	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GFAP—brain cancer	0.000137	0.0011	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000132	0.00106	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HEY1—brain cancer	0.00013	0.00105	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—DLL1—brain cancer	0.000127	0.00103	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP2C9—brain cancer	0.000125	0.001	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000121	0.000975	CbGpPWpGaD
Pentamidine—S100B—Immune System—VAV1—brain cancer	0.000121	0.000975	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000118	0.000954	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000118	0.000954	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000111	0.000894	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.00011	0.000883	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SHH—brain cancer	0.000108	0.000872	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—BSG—brain cancer	0.000106	0.000853	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TRPC6—brain cancer	0.000104	0.000841	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—RELA—brain cancer	0.000103	0.00083	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SMO—brain cancer	0.000103	0.000827	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTCH1—brain cancer	0.000103	0.000827	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—ERBB2—brain cancer	0.000103	0.000825	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000102	0.000819	CbGpPWpGaD
Pentamidine—S100B—Immune System—PDGFRA—brain cancer	9.92e-05	0.000798	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.88e-05	0.000795	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—IDH1—brain cancer	9.11e-05	0.000733	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.08e-05	0.000731	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CTNNB1—brain cancer	8.97e-05	0.000722	CbGpPWpGaD
Pentamidine—S100B—Immune System—IRS2—brain cancer	8.71e-05	0.000701	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.39e-05	0.000676	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOTCH2—brain cancer	8.21e-05	0.000661	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.12e-05	0.000653	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VAV1—brain cancer	7.83e-05	0.00063	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.72e-05	0.000622	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.55e-05	0.000608	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.55e-05	0.000608	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.44e-05	0.000599	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.42e-05	0.000597	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ENO2—brain cancer	7.2e-05	0.00058	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—brain cancer	7.11e-05	0.000572	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.08e-05	0.00057	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HES1—brain cancer	6.73e-05	0.000542	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.64e-05	0.000535	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PDGFRA—brain cancer	6.41e-05	0.000516	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SPP1—brain cancer	6.22e-05	0.000501	CbGpPWpGaD
Pentamidine—S100B—Immune System—RELA—brain cancer	6.01e-05	0.000484	CbGpPWpGaD
Pentamidine—S100B—Immune System—ERBB2—brain cancer	5.97e-05	0.000481	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IRS2—brain cancer	5.63e-05	0.000453	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—brain cancer	5.41e-05	0.000436	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2C9—brain cancer	5.23e-05	0.000421	CbGpPWpGaD
Pentamidine—S100B—Immune System—CTNNB1—brain cancer	5.22e-05	0.000421	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.17e-05	0.000417	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APC—brain cancer	4.97e-05	0.0004	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CG—brain cancer	4.97e-05	0.0004	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2C9—brain cancer	4.94e-05	0.000398	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—brain cancer	4.55e-05	0.000367	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2C9—brain cancer	4.53e-05	0.000365	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—BSG—brain cancer	4.45e-05	0.000358	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—BSG—brain cancer	4.2e-05	0.000338	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—brain cancer	4.14e-05	0.000333	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2C9—brain cancer	4.05e-05	0.000326	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RELA—brain cancer	3.88e-05	0.000313	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—brain cancer	3.86e-05	0.000311	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—BSG—brain cancer	3.85e-05	0.00031	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—IDH1—brain cancer	3.83e-05	0.000308	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2C9—brain cancer	3.72e-05	0.0003	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—IDH1—brain cancer	3.61e-05	0.000291	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—brain cancer	3.5e-05	0.000282	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BSG—brain cancer	3.44e-05	0.000277	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—brain cancer	3.41e-05	0.000275	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—brain cancer	3.38e-05	0.000272	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—IDH1—brain cancer	3.31e-05	0.000267	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—brain cancer	3.3e-05	0.000266	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BSG—brain cancer	3.16e-05	0.000255	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2C9—brain cancer	3.15e-05	0.000254	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ENO2—brain cancer	3.02e-05	0.000243	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—brain cancer	2.97e-05	0.000239	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—IDH1—brain cancer	2.96e-05	0.000238	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—brain cancer	2.94e-05	0.000237	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.94e-05	0.000237	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ENO2—brain cancer	2.86e-05	0.00023	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—brain cancer	2.74e-05	0.00022	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—IDH1—brain cancer	2.72e-05	0.000219	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.7e-05	0.000217	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BSG—brain cancer	2.68e-05	0.000216	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—brain cancer	2.68e-05	0.000215	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ENO2—brain cancer	2.62e-05	0.000211	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.43e-05	0.000196	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.41e-05	0.000194	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO2—brain cancer	2.34e-05	0.000188	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—IDH1—brain cancer	2.3e-05	0.000186	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—brain cancer	2.25e-05	0.000181	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO2—brain cancer	2.15e-05	0.000173	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BSG—brain cancer	2.07e-05	0.000167	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.88e-05	0.000151	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO2—brain cancer	1.82e-05	0.000147	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—IDH1—brain cancer	1.78e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO2—brain cancer	1.41e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—brain cancer	1.39e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—brain cancer	1.31e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—brain cancer	1.2e-05	9.67e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.07e-05	8.63e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—brain cancer	9.86e-06	7.94e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—brain cancer	8.36e-06	6.73e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—brain cancer	6.45e-06	5.19e-05	CbGpPWpGaD
